Skip to main content

Fisher-Price Recalls 253,000 Baby Toys Over Choking Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on April 14, 2025.

By I. Edwards HealthDay Reporter

MONDAY, April 14, 2025 — Fisher-Price has recalled 253,000 baby stroller toys in the U.S. because of a choking risk, according to the U.S. Consumer Product Safety Commission (CPSC).

An additional 4,500 toys sold in Canada have also been recalled, according to a report from CBS News.

The recall involves the "Brunch & Go" stroller toy, a set of make-believe breakfast items including avocado toast, bacon, a tomato and an egg.

The toys are designed to hang from stroller canopies and are marketed as teethers for babies.

"The yolk of the toy egg can crack and create small parts, posing a choking hazard," the CPSC said in a statement.

So far, five people have reported the egg breaking, and two said small pieces ended up in their baby’s mouth. No injuries have been reported, CBS News said.

"Customers should immediately stop using the recalled stroller toys, keep them away from children, and contact Fisher-Price to receive a free replacement stroller toy," the CPSC said.

Fisher-Price, which is owned by Mattel, is asking customers to write the word "Recall" and the product model number on the egg piece, then upload a photo to a recall portal on the Mattel website to get a replacement.

The affected toys have a model number of HGB85, which can be found on a tag attached to the toy toast piece of the toy.

Once you've confirmed a replacement, Fisher-Price says to throw the egg piece away.

The recalled toys were sold between February 2022 and March 2025 at major retailers including Walmart, Amazon, Kohl's, Nordstrom, Marshalls, TJMaxx, Ross, Macy's and Hobby Lobby.

Sources

  • U.S. Consumer Product Safety Commission, April 10, 2025
  • CBS News, April 10, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

FDA Authorizes First AI Platform for Breast Cancer Prediction

FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...

4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone

FRIDAY, June 6, 2025 — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in...

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.